UK: BiVictrix announces plans to delist in search of private funding
AIM-listed biotech company, BiVictriX, is seeking to delist in search of private funding. BiVictriX is a drug discovery and development company applying a proprietary approach...
UK: Assura accelerates diversification strategy with acquisition of Northwest Healthcare UK private hospital portfolio
Canada-based Northwest Healthcare Properties REIT, an owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia, has completed the...
UK: Bupa Health Services acquires London Medical
Bupa Health Services has acquired London Medical, a specialist outpatient clinic located in Harley Street.
London Medical primarily specialises in diabetes treatment and management. As...
UK: CVC DIF to acquire medneo UK
CVC DIF, the infrastructure strategy of private markets manager CVC (via its CIF III fund), is acquiring medneo UK, a leading diagnostic imaging company,...
New Zealand: Livingbridge exits Habit Health to Five V Capital
Mid-market private equity firm, Livingbridge, has announced its exit as an investee of Habit Health to Australia-based Five V Capital. Founded in 2002, Habit...
Ireland: CVC to acquire Mallinckrodt’s Therakos business for US$925m
Dublin-based Mallinckrodt, a global specialty pharmaceutical company, and Luxembourg-based CVC Capital Partners have entered into a definitive agreement under which CVC’s Fund IX will...
UK: n2 Group expands with acquisition of life sciences and healthcare computing consultancy BioTeam
n2 Group, the parent company of NAG, has acquired BioTeam, a life sciences and healthcare consulting company. BioTeam joins STAC, VSNi, and NAG in the...
UK: Agilio enters pharmacy with Mediapharm acquisition
Agilio, a healthcare operations software provider, has acquired specialist pharmacy e-learning business Mediapharm – marking its expansion into a new sector.
Founded in 2001 by...
Switzerland: Ypsomed and MTD complete the sale of the pen needle and BGM business
Ypsomed and Medical Technology and Devices (MTD) have completed the sale of the pen needle and blood glucose monitoring (BGM) systems business. Switzerland-based Ypsomed...
UK: Oxford Nanopore attracts investment from Novo Holdings and completes £80m equity issue
Oxford Nanopore, a UK Listed company developing a new generation of molecular sensing technology based on nanopores, has completed an £80m (US$102m) share issue...
Advertisement
